Randomized, placebo-controlled, phase II study of veliparib in combination with carboplatin and paclitaxel for advanced/metastatic non–small cell lung cancer

SS Ramalingam, N Blais, J Mazieres, M Reck… - Clinical Cancer …, 2017 - AACR
Purpose: PARP plays an important role in DNA repair. Veliparib, a PARP inhibitor, enhances
the efficacy of platinum compounds and has been safely combined with carboplatin and …
被引用次数：84 相关文章

Randomized, Placebo-Controlled, Phase II Study of Veliparib in Combination with Carboplatin and Paclitaxel for Advanced/Metastatic Non-Small Cell Lung Cancer

SS Ramalingam, N Blais, J Mazieres… - … : an official journal …, 2017 - pubmed.ncbi.nlm.nih.gov
Purpose: PARP plays an important role in DNA repair. Veliparib, a PARP inhibitor, enhances
the efficacy of platinum compounds and has been safely combined with carboplatin and …

Randomized, placebo-controlled, phase II study of veliparib in combination with carboplatin and paclitaxel for advanced/metastatic non-small cell lung cancer

SS Ramalingam, N Blais, J Mazieres, M Reck… - Clinical Cancer …, 2017 - elibrary.ru
Purpose: PARP plays an important role in DNA repair. Veliparib, a PARP inhibitor, enhances
the efficacy of platinum compounds and has been safely combined with carboplatin and …
[PDF] archive.org

[PDF][PDF] Randomized, Placebo-Controlled, Phase II Study of Veliparib in Combination with Carboplatin and Paclitaxel for Advanced/Metastatic Non–Small Cell Lung …

SS Ramalingam, N Blais, J Mazieres, M Reck… - scholar.archive.org
Purpose: PARP plays an important role in DNA repair. Veliparib, a PARP inhibitor, enhances
the efficacy of platinum compounds and has been safely combined with carboplatin and …

Randomized, Placebo-Controlled, Phase II Study of Veliparib in Combination with Carboplatin and Paclitaxel for Advanced/Metastatic Non-Small Cell Lung Cancer.

SS Ramalingam, N Blais, J Mazieres… - … Cancer Research: an …, 2016 - europepmc.org
Purpose: PARP plays an important role in DNA repair. Veliparib, a PARP inhibitor, enhances
the efficacy of platinum compounds and has been safely combined with carboplatin and …
[PDF] researchgate.net

[PDF][PDF] Randomized, Placebo-Controlled, Phase 2 Study of Veliparib in Combination with Carboplatin and Paclitaxel for Advanced/Metastatic Non-Small Cell Lung …

SS Ramalingam, N Blais, J Mazieres, M Reck… - researchgate.net
Purpose PARP plays an important role in DNA repair. Veliparib, a PARP inhibitor, enhances
the efficacy of platinum compounds, and has been safely combined with carboplatin and …